February 3 - February 5
The 10th Liquid Biopsy for Precision Oncology Summit stands as a pivotal gathering for those at the forefront of precision medicine. This event brings together a diverse array of stakeholders, from pharma and biotech to academia and patient advocates, unified by the mission to advance liquid biopsy technologies in cancer care. Attendees will benefit from unparalleled insights and strategies across the entire drug development continuum.
What to Expect:
- Engage with a mix of cutting-edge scientists and vendors.
- Experience dynamic plenary sessions and specialized tracks.
- Network with industry leaders and innovative companies.
- Discover the latest advancements in liquid biopsy assays.
- Contribute to discussions overcoming clinical adoption barriers.
Focus Areas:
- ctDNA and MRD technologies
- Multi-omic biomarkers
- Therapeutic pipeline integration
- Regulatory and reimbursement strategies
- Patient-centered diagnostics
Keywords: oncology, liquid biopsy, precision medicine, diagnostics, drug development
Target audience:
This summit is designed for professionals in pharma, biotech, diagnostics, and academia, offering essential insights for those driving innovation in precision oncology.
What attendees say:
Participants frequently highlight the summit’s valuable mix of scientific innovation and practical insights, emphasizing the collaborative spirit and networking opportunities that foster new partnerships and advancements in the field.
Join this transformative summit to connect with peers and pioneer the next breakthroughs in precision oncology.
